Llwytho...
Clinical implications of molecular heterogeneity in triple negative breast cancer
Triple negative breast cancer (TNBC) is a molecularly heterogeneous disease lacking recurrent targetable alterations and thus therapeutic advances have been challenging. The absence of ER, PR and HER2 amplifications, leaves combination chemotherapy as the standard of care treatment option in the adj...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Breast |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4641762/ https://ncbi.nlm.nih.gov/pubmed/26253813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2015.07.009 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|